Last reviewed · How we verify

NCT06059196

Adapting, Expanding and Evaluating ARCHES in Kenya

Completed NA Last updated 1 November 2024
What this trial tests

NA trial testing ARCHES (Addressing Reproductive Coercion in Health Settings) in Reproductive Coercion in 3,928 participants. Completed in 17 May 2024.

Timeline
29 September 2023
Primary endpoint
17 May 2024
17 May 2024

Quick facts

Lead sponsorUniversity of California, San Diego
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment3,928
Start date29 September 2023
Primary completion17 May 2024
Estimated completion17 May 2024
Sites24 locations across Kenya

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Diego

Who can join

Adults 15 to 49, female only, with Reproductive Coercion or Intimate Partner Violence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Document evidence, via cluster randomized controlled trial, of the effectiveness of the ARCHES intervention, a brief, clinic-based counselling intervention demonstrated to reduce intimate partner violence and reproductive coercion and promote women's reproductive health, as scaled in government health facilities in Kenya, to (1) decrease unintended pregnancy, (2) increase family planning uptake and use/continuation, (3) decrease experiences of reproductive coercion and intimate partner violence of women and girls aged 15 to 49 years seeking family planning services, and, to (4) improve quality of care, (5) increase gender equitable attitudes, and, (6) increase self-efficacy to provide comprehensive family planning counseling among providers trained in ARCHES.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Evaluating a scalable ARCHES (Addressing Reproductive Coercion in Health Settings) model in government health facilities in Uasin Gishu county, Kenya: study protocol for a cluster-randomized controlled trial.
    Pearson E, Uysal J, Menzel J, Undie CC, et al · · 2023 · cited 1× · PMID 37848916 · DOI 10.1186/s12978-023-01697-7

Verify or expand the search:

Other University of California, San Diego trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06059196.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing